These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 5548910)

  • 21. Biguanides. A review of history, pharmacodynamics and therapy.
    Schäfer G
    Diabete Metab; 1983; 9(2):148-63. PubMed ID: 6352352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of 1-butyl-biguanidine on blood clotting in patients with adult-type diabetes].
    Kaniak J; Knapik Z; Kotschy M; Kowal-Gierczak B; Paczyńska D
    Pol Tyg Lek; 1974 Jan; 29(4):137-9. PubMed ID: 4820794
    [No Abstract]   [Full Text] [Related]  

  • 23. N 1 -n-butyl-biguanide influence on peripheral assimilation of glucose.
    Mincu I; Câmpeanu S; Mihalache N; Georgescu-Iancu M
    Rev Roum Med Intern; 1973; 10(2):109-13. PubMed ID: 4697581
    [No Abstract]   [Full Text] [Related]  

  • 24. [On the effect of a new depot biguanide on carbohydrate and protein metabolism in diabetes mellitus].
    Müting D
    Dtsch Med Wochenschr; 1966 May; 91(20):939-46. PubMed ID: 5930204
    [No Abstract]   [Full Text] [Related]  

  • 25. [Lactacidosis in biguanide therapy of diabetes mellitus].
    But H
    Dtsch Med Wochenschr; 1977 Nov; 102(44):1613. PubMed ID: 923437
    [No Abstract]   [Full Text] [Related]  

  • 26. [Lactate acidoses in biguanide therapy of diabetes mellitus].
    Raisp I
    Dtsch Med Wochenschr; 1977 Jul; 102(26):978. PubMed ID: 885082
    [No Abstract]   [Full Text] [Related]  

  • 27. [Results of a clinical study of a group of hospitalized diabetics under treatment with depot buformin].
    Durante F; Scaffidi A; Rotolo G; Rini GB
    Minerva Med; 1978 May; 69(24):1665-72. PubMed ID: 662170
    [No Abstract]   [Full Text] [Related]  

  • 28. [Legal problems in biguanide therapy].
    Maurer H
    Wien Med Wochenschr; 1978; 128(22):707-9. PubMed ID: 735110
    [No Abstract]   [Full Text] [Related]  

  • 29. [The effect of the correction of carbohydrate metabolism on serum lipids and lipoproteins in insulin-dependent diabetics].
    Romics L; Karádi I; Rozenberczki M; Kammerer L
    Orv Hetil; 1980 Dec; 121(51):3113-6. PubMed ID: 7012750
    [No Abstract]   [Full Text] [Related]  

  • 30. [Biguanide derivative monotherapy in diabetes].
    Rojszykowa E
    Pol Tyg Lek; 1973 May; 28(19):694-6. PubMed ID: 4710467
    [No Abstract]   [Full Text] [Related]  

  • 31. [Activity of the pancreas glycogenase under oral biguanide and tolbutamide loading in diabetes].
    Schilling I; Jutzi E
    Dtsch Z Verdau Stoffwechselkr; 1967 Feb; 26(4):180-5. PubMed ID: 5595284
    [No Abstract]   [Full Text] [Related]  

  • 32. [A new derivative of the biguanide series. Its role in the treatment of diabetes].
    Journ Annu Diabetol Hotel Dieu; 1976 May; ():341-4. PubMed ID: 1011423
    [No Abstract]   [Full Text] [Related]  

  • 33. [Action of phenyl-ethyl-biguanide on the behavior of the induced per os hyperglycemia curve in patients with so-called biologic diabetes].
    Gérard V
    Diabete; 1970; 18(1):50-2. PubMed ID: 5509651
    [No Abstract]   [Full Text] [Related]  

  • 34. [Study of a new delayed-action biguanide].
    Plauchu M; Pousset G; Chapuy H; Amourdedieu J; Tuaillon J
    Lyon Med; 1969 Oct; 222(35):467-76. PubMed ID: 5401952
    [No Abstract]   [Full Text] [Related]  

  • 35. [Influenza epidemic in 1971 in diabetics treated with 1-butyl-biguanidine hydrochloride (Silubin retard) and 1-phenylethyl-biguanidine hydrochloride (Phenformin)].
    Babiński S; Giermaziak H
    Pol Tyg Lek; 1973 Nov; 28(46):1815-7. PubMed ID: 4771858
    [No Abstract]   [Full Text] [Related]  

  • 36. [Therapy of diabetes mellitus with biguanides].
    Frey H
    Tidsskr Nor Laegeforen; 1968 Apr; 88(8):704-5. PubMed ID: 5671767
    [No Abstract]   [Full Text] [Related]  

  • 37. [Study on fluctuations of serum lipids in patients with diabetes mellitus. With special reference to effects of control level and therapy].
    Okamoto Y; Nakabayashi H; Nakano H; Fujimori Y; Tsujii T
    Rinsho Byori; 1988 Oct; 36(10):1195-200. PubMed ID: 3246732
    [No Abstract]   [Full Text] [Related]  

  • 38. [Biguanides and lipid metabolism].
    Frey H
    Tidsskr Nor Laegeforen; 1970 Feb; 90(3):322-3. PubMed ID: 5430212
    [No Abstract]   [Full Text] [Related]  

  • 39. [A hypoglycemizing sulfamide associated with biguanide in the treatment of type I diabetes in adults].
    Plauchu M; Thevenon P
    Lyon Med; 1968 Oct; 220(42):953-63. PubMed ID: 5742623
    [No Abstract]   [Full Text] [Related]  

  • 40. [Attempts of modification of the serum lipid fractions in diabetics].
    Krámer M; Balogh P
    Dtsch Z Verdau Stoffwechselkr; 1968; 28(5):345-51. PubMed ID: 5731589
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.